Home › Funds › Point72 Asset Management › CLYM
Point72 Asset Management position in CLYM
CLIMB BIO INC · Health Care
Latest position (Q1 2026)59.09K sh
Reported value held$404.77K
Portfolio Weight0.00%
First reportedQ1 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 142.33K | $1.19M | New |
| Q3 2024 | 590.95K | $3.01M | New |
| Q4 2025 | 716.68K | $2.87M | New |
| Q1 2026 | 59.09K | $404.77K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CLYM
- Fidelity Management & Research (FMR) 6.79M sh · $88.55M · Q2 2026
- UBS Group AG 3.40M sh · $44.40M · Q2 2026
- BlackRock Inc 2.35M sh · $30.71M · Q2 2026
- Citadel Advisors 1.30M sh · $16.93M · Q2 2026
- Millennium Management 908.20K sh · $11.84M · Q2 2026
- Geode Capital Management 782.20K sh · $10.20M · Q2 2026
- Vanguard Group 1.34M sh · $5.36M · Q4 2025
- Invesco Ltd 373.44K sh · $4.87M · Q2 2026
- Morgan Stanley 365.09K sh · $4.76M · Q2 2026
- Northern Trust Corp 330.29K sh · $4.31M · Q2 2026
- Renaissance Technologies 192.70K sh · $2.51M · Q2 2026
- Manulife Financial 164.71K sh · $2.15M · Q2 2026